Xtant Medical (XTNT) Projected to Announce Earnings on Monday

Xtant Medical (NYSEAMERICAN:XTNT – Get Free Report) is expected to be announcing its Q3 2026 results before the market opens on Monday, November 16th. Analysts expect Xtant Medical to post earnings of ($0.0250) per share and revenue of $25.48 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Monday, November 16, 2026 at 8:30 AM ET.

Xtant Medical Stock Performance

Shares of XTNT opened at $0.27 on Friday. The business’s fifty day simple moving average is $0.32 and its two-hundred day simple moving average is $0.44. The company has a current ratio of 2.16, a quick ratio of 1.05 and a debt-to-equity ratio of 0.18. Xtant Medical has a 12 month low of $0.26 and a 12 month high of $0.84. The company has a market cap of $38.12 million, a price-to-earnings ratio of -3.40 and a beta of -0.19.

Analyst Upgrades and Downgrades

Separately, Loop Capital set a $1.00 price target on Xtant Medical in a report on Wednesday, September 2nd. Two investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $1.00.

Read Our Latest Analysis on XTNT

About Xtant Medical

(Get Free Report)

Xtant Medical Group, Inc. develops and markets medical products used in spine surgery. Its portfolio includes spinal implant systems and biologic products intended to support bone growth and spinal fusion. The company serves surgeons and healthcare providers, primarily in the United States, and also reaches select international markets through distribution relationships. Its products are used in procedures to treat spinal conditions and support stabilization or fusion. Xtant Medical’s business brings together spinal-device and biologics operations, including products developed through acquisitions.

Read More

Earnings History for Xtant Medical (NYSEAMERICAN:XTNT)

Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.